Did we miss this one? In “Scientists’ Elusive Goal: Reproducing Study Results” (Wall Street Journal, December 2, 2011), Gautam Naik explains,
Two years ago, a group of Boston researchers published a study describing how they had destroyed cancer tumors by targeting a protein called STK33. Scientists at biotechnology firm Amgen Inc. quickly pounced on the idea and assigned two dozen researchers to try to repeat the experiment with a goal of turning the findings into a drug.
They didn’t and the project was scrapped.
That’s the difference, of course, between real science and Dudgeon science like Darwinism, where any result works, and self-righteous posturing stands in for results.
Of course, real science can be heartbreaking, like life.